US Stock Futures Signal Lower Start On Wall Street

Loading...
Loading...
Pre-open movers
US stock futures dropped in early pre-market trade. Futures for the Dow Jones Industrial Average dropped 49 points to 15,690.00, while the Standard & Poor's 500 index futures fell 6.10 points to 1,787.40. Futures for the Nasdaq 100 index declined 6 points to 3,552.00.
A Peek Into Global Markets
European markets were mostly higher today, with the Spanish Ibex Index dropping 0.93%, London's FTSE 100 index gaining 0.02% and STOXX Europe 600 Index climbing 0.01%. German DAX 30 index rose 0.08% and French CAC 40 Index climbed 0.23%. French industrial output dropped 0.3% in December versus November, while Italy's industrial production declined 0.9% versus November. Asian markets ended mixed today. Japan's Nikkei Stock Average surged 1.77%, Hong Kong's Hang Seng Index dropped 0.27%, China's Shanghai Composite Index rose 2.03% and India's BSE Sensex declined 0.21%. Japan's December current-account deficit widened to ¥638.6 billion yen ($6.23 billion), from November's ¥592.8 billion.
Broker Recommendation
Analysts at Morgan Stanley upgraded American Express Company
AXP
from “equal-weight” to “overweight.” The price target for American Express has been raised from $90 to $100. American Express shares closed at $87.00 on Friday.
Breaking news
  • Loews L reported a wider fourth-quarter loss. Loews posted a quarterly net loss of $198 million, or $0.51 per share. To read the full news, click here.
  • Helen of Troy HELE today announced that its Board of Directors has authorized the repurchase of $550 million of its outstanding common shares in keeping with its stated intention, first noted in April 2013, to return to shareholders capital not otherwise deployed for strategic acquisitions. To read the full news, click here.
  • CNA Financial CNA swung to a profit in the fourth quarter. CNA Financial posted a quarterly profit of $221 million, or $0.82 per share, versus a year-ago loss of $9 million, or $0.03 per share. To read the full news, click here.
  • Conatus Pharmaceuticals CNAT today announced the appointment of two additional independent members to the Conatus Board of Directors: Daniel L. Kisner, M.D. and Preston S. Klassen, M.D., M.H.S. To read the full news, click here.
Loading...
Loading...
Market News and Data brought to you by Benzinga APIs
Posted In: NewsEurozoneFuturesGlobalPre-Market OutlookMarketsMorgan StanleyUS Stock Futures
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...